SALVATORE SAVATTA: Open Payments
NPI 1164670717 · CRANFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,867 in 237 payments from 16 companies in 2025. Trend: 2023 $10,996 · 2024 $13,605 · 2025 $6,867
Speaker / faculty: $4,375Food & beverage: $2,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $4,897 |
| Neurocrine BioSciences, Inc. | 50 | $365 |
| Otsuka America Pharmaceutical, Inc. | 28 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $268 |
| E.R. Squibb & Sons, L.L.C. | 26 | $241 |
| Axsome Therapeutics, Inc. | 18 | $187 |
| Alkermes, Inc. | 19 | $184 |
| Teva Pharmaceuticals USA, Inc. | 5 | $84 |
| Supernus Pharmaceuticals, Inc. | 5 | $71 |
| Janssen Pharmaceuticals, Inc | 4 | $68 |
Products named: VRAYLAR, INGREZZA, REXULTI, CAPLYTA, COBENFY, Sunosi, LYBALVI, Auvelity.
Industry payments across NJ — which companies pay providers there.
